Which medication is contraindicated with Tessalon Perles (benzonatate)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 16, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Benzonatate (Tessalon Perles) Contraindications

Benzonatate is contraindicated in patients at high risk of aspiration, and should be used with extreme caution or avoided entirely in frail individuals with serious illnesses, as its local anesthetic effect can cause oropharyngeal anesthesia that impairs protective airway reflexes. 1

Primary Contraindication: Aspiration Risk

  • Patients with impaired swallowing or airway protection should not receive benzonatate because it acts as a local anesthetic on the oropharynx, which can eliminate protective cough and gag reflexes, dramatically increasing aspiration risk. 1

  • This is particularly critical in frail cancer patients, elderly individuals, or those with neurological conditions affecting swallowing. 1

  • The first dose must be administered in an inpatient setting to monitor for reflex bronchospasm, and patients must avoid food and drink for at least one hour after each dose. 1

Relative Contraindications

Pregnancy and Lactation

  • Benzonatate should be used with caution in pregnant or breastfeeding individuals due to limited safety data, requiring individualized risk-benefit assessment. 1

Drug Interactions

  • While not explicitly stated as contraindications in the provided evidence, benzonatate shares structural similarity with local anesthetics like tetracaine and procaine, suggesting caution with other medications affecting cardiac conduction or sodium channels. 2

Clinical Context for Use

  • Benzonatate is reserved for opioid-resistant cough that has failed to respond to peripheral antitussives, not as first-line therapy. 3, 1

  • The typical dosing is 100-200 mg up to four times daily. 3, 1

  • Severe toxicity can occur rapidly with overdose, including seizures, cardiac arrest, dysrhythmias, and death, particularly with intentional ingestions. 4, 5, 6

Important Safety Considerations

  • Benzonatate inhibits voltage-gated sodium channels (including Nav1.7) similar to local anesthetics, which explains both its therapeutic effect and toxicity profile. 2

  • Serious adverse effects occurred in 22% of intentional overdoses but were rare (0.7%) in unintentional exposures in one poison center review. 6

  • Deaths have been reported even in young patients, with cardiac arrest occurring within 1-2 hours of ingestion. 4, 5

References

Guideline

Benzonatate Safety and Contraindications

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Cardiac Arrest Due to Benzonatate Overdose.

The American journal of case reports, 2019

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.